1,516 articles
Alberico Catapano
Alberico L. Catapano, born 1952, is an Italian pharmacologist at the University of Milan who studies lipid metabolism and atherosclerosis, chaired the 2016 ESC/EAS dyslipidaemia guidelines, and led the LIPIGEN registry.
Albert E. Renold
Albert E. Renold (1923–1988) was a Swiss physician and diabetes researcher known for work on insulin secretion and action, professor of medicine at Geneva after a career at Harvard.
Albert L. Waldo
Albert L. Waldo (1936–2023) was an American cardiologist and cardiac electrophysiologist who coined "transient entrainment," researched atrial fibrillation, and held a Case Western Reserve professorship.
Albert Schömig
Albert Schömig, born 1946, is a German cardiologist who led the ISAR trials of antiplatelet therapy after coronary stenting and held the Chair of Internal Medicine at the Technical University of Munich from 1992 to 2012.
Albert Starr
Albert Starr (1926–2024) was an American cardiovascular surgeon who, with engineer Lowell Edwards, developed and implanted the first successful artificial heart valve in Portland, Oregon, in 1960.
Alberto Zanchetti
Alberto Zanchetti (1926–2018) was an Italian physician-scientist at the University of Milan who led landmark hypertension trials, including the Syst-Eur trial, and edited the Journal of Hypertension.
Aldo Pinchera
Aldo Pinchera (1934–2012) was an Italian physician and endocrinologist who founded the Pisan school of endocrinology and built the University of Pisa into a leading thyroid research center.
Alejandro G. Biasotti
Alejandro G. Biasotti was an Argentine researcher and physician who co-authored the 1930 studies conducted in Buenos Aires. These experiments elucidated the pituitary's role in pancreatic diabetes.
Alexander Pfeifer
Alexander Pfeifer is a German pharmacologist who has directed the Institute of Pharmacology and Toxicology at the University of Bonn since 2006, studying brown fat and obesity.
Alexandra C. McPherron
Alexandra C. McPherron is a molecular biologist who co-discovered myostatin, the secreted protein that limits skeletal muscle growth, at Johns Hopkins, then studied its metabolic effects at the NIH.
Alfred E. Buxton
Alfred E. Buxton is an American cardiac electrophysiologist who directs clinical electrophysiology at Beth Israel Deaconess Medical Center and led the MUSTT trial, which shaped defibrillator selection.
Alfred L. George
Alfred L. George Jr. is an American pharmacologist, chair of Pharmacology at Northwestern University Feinberg School of Medicine, known for research on inherited ion channel disorders called channelopathies.
Ali J. Marian
Ali J. Marian is a physician-scientist in cardiovascular genetics, Professor and Director of the Center for Cardiovascular Genetics at UTHealth Houston, known for research on hereditary cardiomyopathies.
Aline Andres
Aline Andres is a nutrition scientist and professor of pediatrics at UAMS, elected to the National Academy of Medicine in 2025 for research on early-life nutrition.
Allan D. Sniderman
Allan D. Sniderman is a Canadian cardiologist at McGill University in Montreal, known since 1980 for establishing apolipoprotein B as a better marker of cardiovascular risk than LDL cholesterol.
Allan D. Struthers
Allan D. Struthers, born 1952, is Emeritus Professor of Cardiovascular Medicine at the University of Dundee, known for research on heart failure, BNP testing, and allopurinol.
Allan L. Klein
Allan L. Klein is a cardiologist at Cleveland Clinic who led the landmark 2001 TEE-guided cardioversion trial and the phase 3 RHAPSODY trial of rilonacept for recurrent pericarditis.
Allan M. Lefer
Allan M. Lefer (1936–2018) was an American cardiovascular physiologist who chaired the Department of Physiology at Thomas Jefferson University, identified myocardial depressant factor, and reported prostacyclin's heart-protective effects.
Allan M. Ross
Allan M. Ross is an American cardiologist, professor of medicine at the George Washington University Medical Center, known for leading randomized trials of adjunctive drug therapy for heart attack.
Allan S. Jaffe
Allan S. Jaffe is an American cardiologist and laboratory medicine specialist at Mayo Clinic in Rochester, Minnesota, a leading figure in cardiac troponin testing and myocardial infarction definition.
Allen J. Taylor
Allen J. Taylor is an American cardiologist who chairs cardiology at MedStar Heart and Vascular Institute in Washington, D.C., after 20 years in the United States Army at Walter Reed.
Allen M. Spiegel
Allen M. Spiegel is an American physician-scientist and endocrinologist whose G-protein research clarified inherited endocrine disorders, and who directed NIDDK from 1999 to 2006 before becoming Dean of Albert Einstein College of Medicine.
Allison B. Goldfine
Allison B. Goldfine is an American physician-scientist in endocrinology and diabetes at Joslin Diabetes Center, known for research on insulin sensitivity, inflammation in obesity, and cardiovascular safety of diabetes therapies.
Alvin C. Powers
Alvin C. Powers is a Vanderbilt University physician-scientist in diabetes and pancreatic islet biology, chief of its diabetes division from 2010 to 2025 and a 2017 ADA president.
Alvin P. Shapiro
Alvin P. Shapiro (born 1920) was an American physician and hypertension researcher at the University of Pittsburgh School of Medicine who studied how stress affects blood pressure.
Ambarish Pandey
Ambarish Pandey is an American cardiologist and physician-scientist at UT Southwestern Medical Center in Dallas, specializing in preventive cardiology and heart failure with preserved ejection fraction.
Amir Lerman
Amir Lerman (1956–2026) was an Israeli-born cardiovascular physician-scientist at Mayo Clinic in Rochester, Minnesota, who established coronary endothelial dysfunction as a measurable marker of early coronary artery disease.
Amir Tirosh
Amir Tirosh is an Israeli physician-scientist in endocrinology and diabetes who directs diabetes research at Sheba Medical Center, Tel-Hashomer, and teaches at Tel Aviv University and Harvard.
Amit V. Khera
Amit V. Khera is an American cardiologist and human geneticist known for genome-wide polygenic scores showing inherited coronary artery disease risk can be quantified from birth.
Anath Shalev
Anath Shalev, MD, is an endocrinologist and diabetes researcher who directs the UAB Comprehensive Diabetes Center and led the 2018 verapamil trial in type 1 diabetes.